Search for Bayer AG and
    1. July 1, 2015

      Pharma groups eye healthy returns from animal drugs market

      A treatment for dogs with itchy skin has turned out to be something of a tonic for investors. Apoquel launched last year and...

    2. June 10, 2015

      Bayer sells diabetes unit to Panasonic Healthcare for €1.02bn

      KKR-backed Panasonic Healthcare has agreed to buy the diabetes business of Germany’s Bayer for €1.02bn. The deal will...

    Special Reports

    1. Special Report: Doing Business in Lyon 2013

      Urban renewal is at the heart of ambitions to rise up the rankings in the economic pre...
    2. Health: Emerging Markets

      From the rising scourge of diabetes to the Ebola epidemic, responses around the world ...
    Search more Special Reports on this topic.

    1. May 4, 2015

      Top European companies boost number of women in leadership roles

      Twenty-two of Europe’s largest multinationals have increased the proportion of women in leadership positions faster than...

    2. April 30, 2015

      Weak euro lifts European drugmakers

      Sanofi and Bayer reported strong first-quarter results and raised guidance for the full year on Thursday, as drugmakers in...

    3. April 26, 2015

      No end in sight to wave of pharma dealmaking

      Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the...

    4. April 22, 2015

      Studies strengthen insecticide link to bee population decline

      Two studies have added powerful scientific evidence to the view that agricultural pesticides are contributing to a decline...

    5. April 5, 2015

      UK reprieve for three cancer drugs

      Three cancer drugs that were supposed to be removed from the National Health Service on cost grounds have been granted a...

    6. February 26, 2015

      Bond issuers increasingly turn to hybrids

      The heavily oversubscribed sale of a €5bn hybrid bond by Total , the French oil group — the largest such issue on a single...

    7. February 20, 2015

      Five big challenges facing Sanofi’s new chief Olivier Brandicourt

      Sanofi’s four-month search for a new chief executive came to an end on Thursday night when it was announced that Olivier...

    8. February 19, 2015

      Sanofi appoints Brandicourt as CEO

      Sanofi has named Olivier Brandicourt of Bayer as its new chief executive, ending a four-month search to replace Chris...

    9. February 4, 2015

      Ackman’s Pershing Square secures seat on Zoetis board

      Bill Ackman, the billionaire hedge fund activist, has parachuted one of his representatives on to the board of Zoetis, the...

    10. December 12, 2014

      Bayer loses bid to block cheap version of cancer drug in India

      Bayer has lost its bid to block a cheap version of the German company’s Nexavar cancer drug from the Indian market in a...

    11. December 8, 2014

      Mizuho Financial Group focuses on lending beyond Japan blue-chips

      The president of Mizuho Financial Group has vowed to do more lending outside Japan, anticipating higher margins and less...

    12. November 28, 2014

      How to invest in petcare

      Keeping animals can be a notoriously expensive whim. Beyond the regular costs of feeding a pet are the unexpected veterinary...

    13. November 24, 2014

      Bayer to use IPO funds to cut debt and buy consumer drugs

      Bayer will use the billions it expects to raise from the initial public offering of its plastic business to pay down debt...

    14. November 11, 2014

      Ackman-led team takes 10% stake in Zoetis

      The activist investor Bill Ackman is leading a $2.2bn raid on Zoetis, the animal vaccines and medications business spun off...

    15. October 30, 2014

      Bayer raises guidance as new drugs drive sales

      Bayer’s shift towards life sciences including the acquisition of Merck’s consumer health business has led the German...

    16. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    17. October 13, 2014

      FT-BC Index: Treasures and grumbles

      It is interesting to see what puts companies right at the top of the index, but also to highlight hidden nuggets elsewhere....

    18. September 19, 2014

      Letter from Lex: ending a relationship

      It has been a week for thinking about break-ups, and not just in Scotland. Over on the west coast of the US there has also...

    19. September 18, 2014

      Bayer: some of the parts

      Break it up, spin it, flog it, float it. Demergers are popular, partly because they are easily done – on paper. Every MBA...

    20. September 18, 2014

      Bayer plans float of plastics business and focus on life sciences

      Bayer is planning to float its plastics business in what would be one of the biggest European initial public offerings for...

    21. July 28, 2014

      Drugmakers juggle non-core assets

      Reckitt Benckiser’s planned spin-off of its pharmaceuticals division adds to a dizzying range of deals in the...

    22. July 28, 2014

      GSK and Reckitt: pharming out

      Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

    23. July 10, 2014

      Corporate bond sales hit five-year highs

      Global companies have turned to international debt markets in the first half of 2014 to meet their funding needs, seizing on...

    24. July 6, 2014

      Drugmakers warn on South Korea pricing policy

      International pharmaceutical companies have warned Seoul that they are holding back new medicines from the country’s market,...

    25. June 24, 2014

      Corporate videos put employees in the frame

      Many people use YouTube and Facebook to achieve “15 minutes of fame” in their personal lives by making videos about their...

    26. June 8, 2014

      Japanese drugmakers sit out global M&A party

      Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

    27. May 9, 2014

      Week in Review, May 10

      A round up of some of the week’s most significant corporate events and news stories. Paris keeps pressure on Alstom over...

    28. May 9, 2014

      Letter from Lex: dealing in governance

      Readers, It’s not just tech stocks any more. Shown any sign of weakness and sellers will come after any would-be growth...

    29. May 7, 2014

      Lanxess to raise 10% more capital

      Lanxess is set to issue new shares equivalent to 10 per cent of its equity capital as new chief executive Matthias Zachert...

    30. FT Alphaville

      May 6, 2014

      The Closer

      FURTHER FURTHER READING - Billionaire hedgies made money the old-fasioned way. - A thousand cuts and the last mile problem....

    31. May 6, 2014

      Bayer / Merck: the right price?

      This looks expensive. Any deal done at 21 times historic earnings before interest, tax, depreciation and amortisation...

    32. May 6, 2014

      Bayer acquires Merck’s consumer healthcare business for $14.2bn

      Germany’s Bayer has agreed to buy Merck’s consumer healthcare business for $14.2bn, acquiring brands including Coppertone...

    33. May 1, 2014

      Reckitt Benckiser no longer in talks to buy Merck unit

      Reckitt Benckiser is no longer in talks to buy Merck’s consumer healthcare division, paving the way for a rival to land the...

    34. April 28, 2014

      Bayer expected to focus on life sciences

      A rebound in German conglomerate Bayer’s plastics business has fuelled speculation that the division could be sold as part...

    35. April 28, 2014

      Reckitt and Bayer circle Merck auction of consumer healthcare

      Merck of the US is in the final stages of selling its consumer healthcare unit for close to $14bn, with Reckitt Benckiser...

    36. March 12, 2014

      Bayer: high hopes

      The 2014 targets from Bayer: 5 per cent sales growth; growth in earnings before interest, tax, depreciation and amortisation...

    37. January 26, 2014

      Lanxess chief Heitmann to quit as profits fall

      Lanxess chief executive Axel Heitmann is to stand down after the speciality chemical company’s profits were hit by growing...

    38. December 26, 2013

      Drug groups pin hopes on Iran market potential

      When Pfizer sold a small batch of medicines to Iran last year, the process was painful. The pharmaceutical group needed...

    Search for Bayer AG and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Lex on whether demerger makes real business sense...
      Thu Sep 18 14:58:15 GMT 2014

      Lex on whether demerger makes real business sense

    2. Lex on potential bidding war for Schiff between Reckitt and Bayer...
      Fri Nov 16 03:43:00 GMT 2012

      Lex on potential bidding war for Schiff between Reckitt...